Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 2/20 | 0.68 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | CA7 | P43166 | 1/20 | 0.57 |
| ▸ | CA9 | Q16790 | 1/20 | 0.57 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.57 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | CTSD | P07339 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27789892 | 0.92 | CTSD (0.60) | CDC25BHTTCA12CA1CA2 | |
| Phthalic Acid SCHEMBL8680432 | 0.90 | HTT (0.75) | CDC25BHTTKMT2ACA12CA1 | |
| SCHEMBL29658169 | 0.90 | CTSD (0.62) | HTTCA12CA1CA2CA7 | |
| SCHEMBL322168 | 0.90 | CTSD (0.62) | HTTCA12CA1CA2CA7 | |
| SCHEMBL3527 | 0.88 | HTT (0.78) | CDC25BHTTKMT2ACA12CA1 | |
| SCHEMBL29365231 | 0.88 | HTT (0.78) | CDC25BHTTKMT2ACA12CA1 | |
| SCHEMBL7085117 | 0.87 | CDC25B (0.57) | CDC25BHTTKMT2ACA12CA1 | |
| SCHEMBL10404879 | 0.86 | HTT (0.75) | CDC25BHTTKMT2ACA12CA1 | |
| Ammonia Solution, Strong SCHEMBL22437491 | 0.86 | HTT (0.75) | CDC25BHTTKMT2ACA12CA1 | |
| Bicarbonate SCHEMBL21517635 | 0.86 | HTT (0.75) | CDC25BHTTKMT2ACA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4093577-A | ESTERIFYING WITH AN UNSATURATED FATTY ACID A RESIN PRODUCED FROM A DIALKYLAMINOBENZOIC ACID OR A CARBOXY-CONTAINING BENZOPHENONE WITH A POLYBASIC ACID AND A POLYHYDRIC ALCOHOL | TOYO INK MANUFACTURING CO., LTD. (JA) | 1978-06-06 | — | — | US | claimed |
| EP-1207161-B1 | NOVEL ISOINDOLE DERIVATIVES | BANYU PHARMA CO LTD (JP) | 2006-01-18 | — | — | EP | disclosed |
| US-6777410-B2 | SUCH AS 9-(2-METHOXYPHENYL)-3-(1-METHYLETHYL)-(1,3)OXAZOLO-(2,3)ISOINDOLE-2,5(3H,9H)-DIONE; DIABETES AND COMPLICATIONS; OBESITY | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2004-08-17 | — | — | US | disclosed |
| US-20040053923-A1 | Novel isoindole derivatives | BANYU PHARMACEUTICAL CO., LTD. | 2004-03-18 | — | — | US | disclosed |
| US-6608098-B1 | Diabetes or obesity, 2-(4-(3-isopropyl-2,5-dioxo-2,3-dihydro-1H-pyrrolo(2,1-a) isoindol-9(5H)-yl)phenoxy)-N-propylacetamide | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2003-08-19 | — | — | US | disclosed |
| EP-1207161-A1 | NOVEL ISOINDOLE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2002-05-22 | — | — | EP | disclosed |
| EP-0127203-B1 | NEW PHTHALIDE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND RECORDING SYSTEM UTILIZING THE SAME AS COLOURLESS CHROMOGENIC MATERIAL | KANZAKI PAPER MANUFACTURING CO., LTD (JP) | 1989-06-28 | — | — | EP | disclosed |
| US-4093577-A | ESTERIFYING WITH AN UNSATURATED FATTY ACID A RESIN PRODUCED FROM A DIALKYLAMINOBENZOIC ACID OR A CARBOXY-CONTAINING BENZOPHENONE WITH A POLYBASIC ACID AND A POLYHYDRIC ALCOHOL | TOYO INK MANUFACTURING CO., LTD. (JA) | 1978-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040053923-A1 | Novel isoindole derivatives | GPR119, SLC5A2, SLC5A1 | CDC25B 3915/4885HTT 3195/4885KMT2A 2387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.